Goldman Sachs
INSM icon

Goldman Sachs’s Insmed INSM Stock Holding History

Goldman Sachs’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-240,000
Closed -$24.2M – 6493
2025
Q2 		$24.2M Buy
+240,000
New +$18.4M ﹤0.01% 1965
2016
Q2 		– Sell
-59,500
Closed -$754K – 7129
2016
Q1 		$754K Sell
59,500
-500
-0.8% -$6.57K ﹤0.01% 4336
2015
Q4 		$1.09M Hold
60,000
– – ﹤0.01% 4215
2015
Q3 		$1.11M Buy
60,000
+10,000
+20% +$250K ﹤0.01% 4368
2015
Q2 		$1.22M Buy
+50,000
New +$1.14M ﹤0.01% 4349
2015
Q1 		– Sell
-49,600
Closed -$767K – 7180
2014
Q4 		$767K Buy
+49,600
New +$704K ﹤0.01% 4864
2014
Q3 		– Sell
-281,200
Closed -$5.62M – 7179
2014
Q2 		$5.62M Sell
281,200
-303,200
-52% -$4.49M ﹤0.01% 2912
2014
Q1 		$11.1M Buy
+584,400
New +$11.1M ﹤0.01% 2285

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs's INSM Position: Q1 2026 in Review

Goldman Sachs reduced its Insmed (INSM) stake by 24% in Q1 2026, selling an estimated $46.5M and leaving 942,646 shares worth $154M. The position accounts for 0.02% of the portfolio, ranked #808.

Goldman Sachs first reported a position in INSM in Q3 2013 and has held it in 51 quarters since. The position peaked at $217M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Goldman Sachs held 942,646 shares of Insmed worth $154M as of Q1 2026.
  • Goldman Sachs sold 302,267 Insmed shares in Q1 2026, an estimated $46.5M.
  • Insmed made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #808 holding.
  • Goldman Sachs first reported a position in Insmed in Q3 2013 and has held it in 51 quarters since.
  • Goldman Sachs's Insmed position peaked at $217M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.